List your tool

Head to head · 2026

Qureight vs RetinAI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Qureight

Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab

4.1Not listed

Visit Qureight (opens Qureight in a new tab)

RetinAI

CE-marked retinal imaging analysis for clinics, trials and pharmaceutical research

4.1Not listed

Visit RetinAI (opens RetinAI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Qureight does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Tie

    4.1 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onQureightRetinAI
Our rating4.14.1
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
  • Glass8 and Vascul8 for vascular and parenchymal measures
  • Central reads and endpoint discovery for trials
  • Imaging data curation and quality control
  • Built for pulmonary fibrosis, hypertension and bronchiectasis trials
  • OCT Atlas CE-marked for AMD, DR, DME and glaucoma
  • LuxIA CE-MDR certified for diabetic retinopathy screening
  • Discovery UNITY for unified imaging data
  • Editions for multi-centre clinical studies and for clinics
  • Automatic segmentation across device formats
Pros
  • Consistent measurement reduces the variability that costs trial power
  • Named biomarkers rather than a generic imaging claim
  • Focused deeply on respiratory and cardiac disease
  • CE marking separates it from research-only imaging tools
  • Handles data from multiple scanner formats
  • Serves clinics, trials and pharma from one platform
Cons
  • No published pricing; sold to trial sponsors
  • Biomarkers need regulatory acceptance per context of use
  • Narrow therapeutic focus by design
  • No published pricing
  • CE marking is not FDA clearance; availability differs by market
  • Supports the ophthalmologist's decision rather than replacing it
CompanyQureight LtdIkerian AG

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is Qureight better than RetinAI?

In our reviews Qureight scores 4.1 and RetinAI scores 4.1. The better pick depends on the job. Qureight: Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. RetinAI: CE-marked retinal imaging analysis for clinics, trials and pharmaceutical research.

Which is cheaper, Qureight or RetinAI?

Qureight: see pricing. RetinAI: see pricing.

Do Qureight and RetinAI have free plans?

Neither lists a free plan.

More comparisons